AnaptysBio (ANAB)
(Delayed Data from NSDQ)
$23.43 USD
-0.48 (-2.01%)
Updated Jun 7, 2024 04:00 PM ET
After-Market: $23.43 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Brokerage Reports
0 items in cart
AnaptysBio, Inc. [ANAB]
Reports for Purchase
Showing records 121 - 140 ( 156 total )
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Competitor IL36R Inhibitor Data Supports ANB019''s Chances in GPP and PPP
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: AnaptysBio, Inc.
Industry: Unclassified
Company: AnaptysBio, Inc.
Industry: Unclassified
Company: AnaptysBio, Inc.
Industry: Unclassified
2Q18; Swapping Peanut Allergy for CRSwNP a Positive, Topline Asthma Up Next
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AnaptysBio, Inc.
Industry: Unclassified
Company: AnaptysBio, Inc.
Industry: Unclassified
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: AnaptysBio, Inc.
Industry: Unclassified
EAACI; Additional ANB020 Biomarker Readout Potentially Improves Asthma Chances
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AnaptysBio, Inc.
Industry: Unclassified
HEALTHCARE - The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AnaptysBio, Inc.
Industry: Unclassified
1Q18; Looking Ahead to Atopic Derm and ANB019 Updates at EAACI, Asthma in Q3
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AnaptysBio, Inc.
Industry: Unclassified
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: AnaptysBio, Inc.
Industry: Unclassified
Topline Peanut Allergy Positive, Adds Support to Broad Use in Allergic Diseases
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AnaptysBio, Inc.
Industry: Unclassified
HEALTHCARE - The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AnaptysBio, Inc.
Industry: Unclassified
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: AnaptysBio, Inc.
Industry: Unclassified
4Q, Enticing Risk/Reward Ahead of Peanut Allergy Data this Month
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AnaptysBio, Inc.
Industry: Unclassified
Company: AnaptysBio, Inc.
Industry: Unclassified
Single Shot ANB020 in Atopic Dermatitis with Dupi-like Results for Months
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AnaptysBio, Inc.
Industry: Unclassified
MORNING CALL
Provider: WEDBUSH SECURITIES INC.